CLINICAL_TRIALS ClinicalTrials.gov record update

Open Randomized Study of the Safety, Tolerability, and Pharmacokinetic Parameters of UNIFUZOL® (Solution for Infusions, 1.4%, Manufactured by "NTFF"POLYSAN " Ltd.,Russia) in Healthy Volunteers at Different Rates of Administration (Phase I)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03028285
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:39.193283+00:00
Published At: 2020-07-14T00:00:00+00:00
Record Updated At: 2020-07-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Peripheral Vascular Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-07-14"
protocolSection.identificationModule.nctId: "NCT03028285"
protocolSection.identificationModule.officialTitle: "Open Randomized Study of the Safety, Tolerability, and Pharmacokinetic Parameters of UNIFUZOL\u00ae (Solution for Infusions, 1.4%, Manufactured by \"NTFF\"POLYSAN \" Ltd.,Russia) in Healthy Volunteers at Different Rates of Administration (Phase I)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.